Why is the UK still lagging behind in cancer survival?
Study finds UK performing worse than six comparable countries
The UK’s cancer survival rates still lag behind those of similar countries, a study has found.
In what The Guardian describes as a “major research exercise”, the study in Lancet Oncology examined the one-year and five-year survival of cancer patients in Australia, Canada, Denmark, Ireland, New Zealand, Norway and the UK between 1995 and 2014.
They found that the chances of surviving cancer have improved in the UK, with five-year survival rates for colon cancer up from 48% to 62% and one-year survival for lung, ovarian and oesophageal cancer up by around 15%.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
However, the UK still performed worse than Australia, Canada, Denmark, Ireland, New Zealand and Norway. Cancer Research UK told the BBC that the UK could do better and called for more “investment in the NHS and the systems and innovations that support it”.
It added: “We will not see the necessary improvements in diagnosis and access to treatment unless we have enough of the right staff across our NHS.”
The authors of the study said the different survival rates was partly explained by how swiftly patients get a diagnosis and then get prompt access to effective treatment.
John Butler, a co-author of the report, said “continued investment in early diagnosis and cancer care plays a big part” in survival rates, adding: “Despite our changes we’ve made slower progress than others.”
The Daily Mirror puts it more directly, saying “a lack of funding to boost early diagnosis is why Britain did so poorly”.
In England, the NHS target is for cancer treatment to start within 62 days of an urgent referral in 85% of cases, but 94 out of 131 (around 70%) cancer services in England failed to do that during 2018/19.
Despite this, the Department of Health and Social Care said: “Cancer survival rates are at a record high.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
The alarming rise of cancer in young people
Under the radar Cancer rates are rising, and the cause is not clear
By Devika Rao, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
'Beyond belief': fears of asbestos return
Under the radar Attention is returning to the dangers of the carcinogenic substance
By Chas Newkey-Burden, The Week UK Published
-
What to say to someone who has cancer
The Explainer Saying something is better than nothing but there are some things to avoid too
By Chas Newkey-Burden, The Week UK Published
-
Anastrozole: the daily breast cancer pill tipped to save thousands of lives
The Explainer Existing treatment approved for preventative use under 'pioneering' NHS drug repurposing scheme
By Harriet Marsden, The Week UK Published
-
Good health news: seven surprising medical discoveries made in 2023
In Depth A fingerprint test for cancer, a menopause patch and the shocking impacts of body odour are just a few of the developments made this year
By The Week Staff Published
-
Five good-news cancer breakthroughs in 2023
In Depth Cancer-sniffing ants, ‘Bond villain’ DNA, and vaccine trials are just a few exciting developments in cancer research this year
By The Week Staff Published